U.S. Cancer Spit Test Devices Market to 2032
Overview
The U.S. Cancer Spit Test Devices Market is expected to reach a 597.30 USD Million by 2032 and is projected to grow at a CAGR of 16.52% from 2025 to 2032.
Revenue, 2024 (USD Million)
257.33
Forecast, 2032 (USD Million)
597.30
CAGR, 2024 - 2032
16.52%
Report Coverage
U.S.
U.S. Cancer Spit Test Devices Market 2018-2032 USD Million
U.S. Cancer Spit Test Devices Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 257.33 USD Million
- Projected Market Size (2032): 597.30 USD Million
- CAGR (2025-2032): 16.52%
Key Findings of U.S. Cancer Spit Test Devices Market
- The U.S. Cancer Spit Test Devices Market was valued at 257.33 USD Million in 2024.
- The U.S. Cancer Spit Test Devices Market is likely to grow at a CAGR of 16.52% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Adult in Age Group Segment accounted for the largest share of the market with a revenue of 205.17 USD Million
- The fastest growing segment Liver-Lung Cancer in Application Segment grew Fastest with a CAGR of 22.85% during the forecast period from 2024 to 2032.
U.S. Cancer Spit Test Devices Market Scope
U.S. Cancer Spit Test Devices Market Segmentation & Scope
Product Type
- Others
- Saliva Cryostorage Box
- Bar-Code Labels
- Oral Swab
- Fluid Specific Devices
- Saliva Collection Kit
Site of Collection
- Minor Salivary Gland
- Protid Gland
- Sub-mandibular/Sub-lingual Galnd
Distribution Channel
- Others
- Retail Sales
- Direct Tender
End User
- Others
- Cancer Research Institutes
- Oncology Speciality Clinics
- Diagnostic Laboratories
- Hospitals
Method of Collection
- Others
- Oral Swab
- Passive Drool
Age Group
- Pediatrics
- Adult
Application
- Non-Hodgkin Lymphoma
- Melanoma
- Others
- Leukemia
- Kidney Cancer
- Endometrial Cancer
- Thyroid Cancer
- Oral Cancer
- Pancreatic Cancer
- Prostate Cancer
- Colon and Rectal Cancer
- Breast Cancer
- Liver-Lung Cancer
U.S. Cancer Spit Test Devices Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 257.33 USD Million |
| Market Value in 2032 | 597.30 USD Million |
| CAGR (2025-2032) | 16.52% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product Type,Site of Collection,Distribution Channel,End User,Method of Collection,Age Group,Application |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 257.33 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 257.33 USD Million in 2024.
Segments and Scope
-
U.S. Cancer Spit Test Devices Market to 2032, By Product Type
- Saliva Collection Kit is the largest segment in U.S. Cancer Spit Test Devices Market to 2032 with a revenue of 84.66 USD Million in the year 2024.
- Saliva Collection Kit is the Fastest growing segment in U.S. Cancer Spit Test Devices Market to 2032 with a Growth rate of 18.28 % in forecast period 2025-2032.
-
U.S. Cancer Spit Test Devices Market to 2032, By Site of Collection
- Sub-mandibular/Sub-lingual Galnd is the largest segment in U.S. Cancer Spit Test Devices Market to 2032 with a revenue of 155.74 USD Million in the year 2024.
- Sub-mandibular/Sub-lingual Galnd is the Fastest growing segment in U.S. Cancer Spit Test Devices Market to 2032 with a Growth rate of 17.02 % in forecast period 2025-2032.
-
U.S. Cancer Spit Test Devices Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in U.S. Cancer Spit Test Devices Market to 2032 with a revenue of 177.84 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in U.S. Cancer Spit Test Devices Market to 2032 with a Growth rate of 16.87 % in forecast period 2025-2032.
-
U.S. Cancer Spit Test Devices Market to 2032, By End User
- Hospitals is the largest segment in U.S. Cancer Spit Test Devices Market to 2032 with a revenue of 88.47 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in U.S. Cancer Spit Test Devices Market to 2032 with a Growth rate of 17.71 % in forecast period 2025-2032.
-
U.S. Cancer Spit Test Devices Market to 2032, By Method of Collection
- Passive Drool is the largest segment in U.S. Cancer Spit Test Devices Market to 2032 with a revenue of 142.88 USD Million in the year 2024.
- Passive Drool is the Fastest growing segment in U.S. Cancer Spit Test Devices Market to 2032 with a Growth rate of 17.05 % in forecast period 2025-2032.
-
U.S. Cancer Spit Test Devices Market to 2032, By Age Group
- Adult is the largest segment in U.S. Cancer Spit Test Devices Market to 2032 with a revenue of 205.17 USD Million in the year 2024.
- Adult is the Fastest growing segment in U.S. Cancer Spit Test Devices Market to 2032 with a Growth rate of 16.82 % in forecast period 2025-2032.
-
U.S. Cancer Spit Test Devices Market to 2032, By Application
- Liver-Lung Cancer is the largest segment in U.S. Cancer Spit Test Devices Market to 2032 with a revenue of 43.59 USD Million in the year 2024.
- Liver-Lung Cancer is the Fastest growing segment in U.S. Cancer Spit Test Devices Market to 2032 with a Growth rate of 22.85 % in forecast period 2025-2032.
U.S. Cancer Spit Test Devices Market Company Share Analysis
| Company Name |
|
||
| QIAGEN | |||
| Biocartis | |||
| Abbott | |||
| F. Hoffmann-La Roche Ltd. | |||
| Siemens Healthcare GmbH | |||
U.S. Cancer Spit Test Devices Market Geographical Sales Distribution, 2018-2032 USD Million
U.S. Cancer Spit Test Devices Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Cancer Spit Test Devices Market is segmented based on Segmentation Product Type,Site of Collection,Distribution Channel,End User,Method of Collection,Age Group,Application.
U.S. Cancer Spit Test Devices Market was valued at USD 257.33(Revenue in USD Million) in 2020.
U.S. Cancer Spit Test Devices Market is projected to grow at a CAGR of 16.52% during the forecast period of 2024 to 2032.
The Adult segment is expected to dominate the U.S. Cancer Spit Test Devices Market, holding a largest market share of 205.17 USD Million in 2024
Coming Soon....
U.S. Cancer Spit Test Devices Market Scope
U.S. Cancer Spit Test Devices Market Segmentation & Scope
Product Type
- Others
- Saliva Cryostorage Box
- Bar-Code Labels
- Oral Swab
- Fluid Specific Devices
- Saliva Collection Kit
Site of Collection
- Minor Salivary Gland
- Protid Gland
- Sub-mandibular/Sub-lingual Galnd
Distribution Channel
- Others
- Retail Sales
- Direct Tender
End User
- Others
- Cancer Research Institutes
- Oncology Speciality Clinics
- Diagnostic Laboratories
- Hospitals
Method of Collection
- Others
- Oral Swab
- Passive Drool
Age Group
- Pediatrics
- Adult
Application
- Non-Hodgkin Lymphoma
- Melanoma
- Others
- Leukemia
- Kidney Cancer
- Endometrial Cancer
- Thyroid Cancer
- Oral Cancer
- Pancreatic Cancer
- Prostate Cancer
- Colon and Rectal Cancer
- Breast Cancer
- Liver-Lung Cancer
Frequently Asked Questions
The U.S. Cancer Spit Test Devices Market is segmented based on Segmentation Product Type,Site of Collection,Distribution Channel,End User,Method of Collection,Age Group,Application.
U.S. Cancer Spit Test Devices Market was valued at USD 257.33(Revenue in USD Million) in 2020.
U.S. Cancer Spit Test Devices Market is projected to grow at a CAGR of 16.52% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Cancer Spit Test Devices Market for final year is USD 597.30 (USD Million).
U.S. Cancer Spit Test Devices Market Company Profiling
Frequently Asked Questions
The U.S. Cancer Spit Test Devices Market is segmented based on Segmentation Product Type,Site of Collection,Distribution Channel,End User,Method of Collection,Age Group,Application.
U.S. Cancer Spit Test Devices Market was valued at USD 257.33(Revenue in USD Million) in 2020.
U.S. Cancer Spit Test Devices Market is projected to grow at a CAGR of 16.52% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Cancer Spit Test Devices Market for final year is USD 597.30 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.